Ipratropium Bromide (Sandoz Inc.)
Welcome to the PulseAid listing for the Ipratropium Bromide drug offered from Sandoz Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc. |
NON-PROPRIETARY NAME: | Ipratropium Bromide |
SUBSTANCE NAME: | IPRATROPIUM BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-09-01 |
END MARKETING DATE: | 0000-00-00 |
Ipratropium Bromide HUMAN PRESCRIPTION DRUG Details:
Item Description | Ipratropium Bromide from Sandoz Inc. |
LABELER NAME: | Sandoz Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/2.5mL) |
START MARKETING DATE: | 2011-09-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-7157_a76b5f61-64c0-4a1c-85a4-a7f743fb3250 |
PRODUCT NDC: | 0781-7157 |
APPLICATION NUMBER: | ANDA075693 |
Other IPRATROPIUM BROMIDE Pharmaceutical Manufacturers / Labelers: